Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Voyageur Pharmaceuticals Ltd (OP: VYYRF )

0.0450 UNCHANGED
Streaming Delayed Price Updated: 2:07 PM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0450
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0450
Today's Range 0.0450 - 0.0450
52wk Range 0.0005 - 0.0780
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium
--News Direct-- 
Via News Direct
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium
Proactive Research Analyst Daniel Appiah speaks to Thomas Warner from the Londons studio after publishing a new research note on Canadian medical imaging contrast media company Voyageur Pharmaceuticals... 
Via TheNewswire.com

Performance

YTD
-23.86%
-23.86%
1 Month
-15.09%
-15.09%
3 Month
+11.11%
+11.11%
6 Month
N/A
N/A
1 Year
+37.20%
+37.20%

More News

Read More
Voyageur Pharmaceuticals with a "big market to go for"
Via TheNewswire.com
Voyageur Pharmaceuticals with a "big market to go for"
Via News Direct
Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs
Via TheNewswire.com
Voyageur Pharmaceuticals Ltd. Announces Update To PEA and a Related New Opportunity To Market High Purity USP Barium Sulfate
Via TheNewswire.com
Voyageur Pharmaceuticals Announces Board of Director Changes and 2nd quarter Financial Results
Via TheNewswire.com
Voyageur Pharmaceuticals Ltd. Announces Completion of Private Placement
Via TheNewswire.com
Exposures Product Safety
Voyageur Pharmaceuticals Ltd. Announces Closing of Second Tranche of Private Placement
Via TheNewswire.com
Voyageur Pharmaceuticals Ltd. Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast
Via Get News
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast
Via TheNewswire.com
Exposures Product Safety
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast
Via TheNewswire.com
Exposures Product Safety
Voyageur Pharmaceuticals Ltd. Issued 4th Health Canada License For Radiographic Barium Contrast Product
Via Get News
Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out
Via TheNewswire.com
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.